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Abstract
Background—Some primary care physicians choose not to provide cervical cancer screening.
Purpose—To investigate the characteristics and screening beliefs of family practitioners and 
internists who treat adult women in outpatient settings but perform no routine Pap tests.
Methods—A survey of U.S. primary care physicians (N = 892) was conducted and analyzed in 
2012.
Results—Participants who performed no Pap tests during a typical month (17.2% of family 
practitioners and 44.3% of internists) generally reported that they referred patients to 
gynecologists for cervical cancer screening. The most significant predictor of Pap test non-
provision was agreement that patients are best served by having Pap tests performed by 
gynecologists (AOR = 8.80, 95% CI = 5.58, 13.88, p < 0.001).
Conclusions—The perception that patients benefit from cervical cancer screening administered 
by gynecologists may deter screening in primary care settings, resulting in missed opportunities to 
offer screening to women who are never or rarely screened.
Introduction
In the U.S., both gynecologists and primary care providers perform cervical cancer 
screening. Screening options currently recommended by the U.S. Preventive Services Task 
Force include the Pap test every 3 years for women aged 21–65 years and the Pap test 
administered in conjunction with the human papillomavirus test every 5 years for women 
aged 30–65 years.1
As frontline medical workers, primary care providers may have opportunities to offer 
screening to women who are never or rarely screened—the population in which the majority 
of invasive cervical malignancies occur.2–6 In addition, wait times for gynecologist visits 
vary widely within and between metropolitan areas,7 and primary care providers may offer 
urban women more timely access to screening in some cases. In many rural communities, 
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there are no gynecologists8; thus, primary care providers may be the only screening option 
available locally. Further, cervical cancer screening in primary care settings may support 
comprehensive care delivery—primary care physicians were found to address non-
gynecologic medical problems during preventive gynecologic examinations more often than 
gynecologists.9 This difference may be critical for patients whose well woman visit is their 
only contact with medical care for an extended period.
However, not all primary care providers perform cervical cancer screening. In a 2006–2007 
national survey, 9% of family practitioners and internists reported performing no Pap tests.10 
This study investigated the characteristics and screening beliefs of primary care physicians 
who do not perform routine Pap tests.
Methods
The 2012 DocStyles survey was administered online in July by Porter Novelli (Washington 
DC). Participants were recruited from the Epocrates Honors Panel (>275,000 U.S. health 
professionals) and limited to those who practiced in the U.S., actively saw patients, and had 
practiced for at least 3 years. The survey included a variety of provider groups, but the 
analyses reported here were limited to primary care physicians.
An invitation to participate in the survey was emailed to 2,175 randomly selected internists 
and family practitioners, who matched the 2012 American Medical Association Masterfile 
estimates for age, gender, and region. Quota sampling11 was used to ensure adequate 
representation of all surveyed provider groups. The quota for primary care physicians was 
set at 1,000, but the final two participants responded simultaneously, resulting in a sample of 
1,001. Respondents who did not treat adult female patients (n = 3) and those working in 
primarily inpatient care settings (n = 106) were excluded, which narrowed the sample to 
892. No identifying information was included in the data set provided to investigators, and 
analyses were exempted from CDC IRB approval.
Measures included the number of Pap tests and bimanual pelvic examinations administered 
to asymptomatic, average-risk women during a typical month, as well as other physician and 
practice characteristics. Screening beliefs were assessed with three statements with agree–
disagree–not sure response sets: (1) the reimbursement for Pap tests is typically too low to 
cover the costs associated with providing them; (2) women prefer to receive Pap tests from 
female providers; and (3) patients are generally best served by having Pap tests performed 
by gynecologists. These screening beliefs were identified in a preliminary qualitative study 
conducted by the CDC (CPC, unpublished observations, 2011).
Pairwise Pearson chi-square tests were performed to test the associations between Pap test 
non-provision and physician characteristics, practice characteristics, and screening beliefs 
(Table 1). Variables significantly associated (p < 0.05) with Pap test non-provision in the 
bivariate analyses were included in a forward conditional regression model predicting non-
provision of Pap tests during a typical month. The data were analyzed in 2012 using SPSS 
Statistics, version 21.0 (IBM, Endicott NY).
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Results
More than a quarter of participants (28.4%) reported that they administered no Pap tests to 
asymptomatic, average-risk women during a typical month, and an almost equal percentage 
(28.5%) reported providing no bimanual pelvic examinations to the same population of 
women during a typical month (results not shown). Among those who did not perform Pap 
tests, 13.5% reported that other providers in their offices performed Pap tests, and 80.4% 
reported that they routinely referred patients to gynecologists for cervical cancer screening 
(results not shown).
In the pairwise Pearson chi-square tests, ten variables were significantly associated with Pap 
test provision (Table 1). Six of these ten variables remained significant predictors in the 
multivariate model predicting non-provision of Pap tests during a typical month (Table 2). 
The largest AOR was associated with agreement that patients are best served by having Pap 
tests performed by gynecologists (AOR = 8.80, 95% CI = 5.58, 13.88, p < 0.001).
Discussion
The belief that patients benefit from cervical cancer screening administered by gynecologists 
may deter screening in primary care settings, resulting in missed opportunities to offer 
screening to women who are never or rarely screened. Further research is needed to 
understand the origins of this belief. It is possible that the time constraints of primary care 
visits make it difficult for physicians to administer Pap tests.12 Another contributing factor 
may be the perceived complexity and evolving nature of guidelines for abnormal Pap test 
follow-up.13 Initial screening by a gynecologist affords patients with immediate access to a 
specialist in the event of an abnormal test result.
The higher rate of Pap test non-provision among male physicians in the current study is 
consistent with prior research.14,15 The association between practicing in a Metropolitan 
Statistical Area with a population >5 million and non-provision of Pap tests is likely related 
to the high concentration of gynecologists in these markets.8 Similarly, the observed 
differences by geographic region may also be related to actual or perceived patient access to 
gynecologists. The difference in Pap test non-provision by specialty was muted in the 
multivariate model, suggesting that the striking association found in the bivariate analyses 
was somewhat attributable to underlying variables. Finally, the influence of uncertainty 
about the adequacy of Pap test reimbursement is logical, as physicians who have not 
performed Pap tests for some time may not have a sense of current reimbursement.
It is unknown whether women who have Pap tests administered by gynecologists experience 
different clinical outcomes than those screened by primary care physicians. Compared with 
gynecologists, primary care physicians have been found to more closely adhere to cervical 
cancer screening recommendations,10,16 but their follow-up care of abnormal Pap test results 
was reported to be less consistent with guidelines.17 However, Pap test administration by 
primary care physicians has been found to support comprehensive care delivery.9
Whether Pap test provision by U.S. primary care physicians is currently decreasing or 
increasing is also unknown. The survey results reported here should not be interpreted as 
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firm national estimates, as the use of quota sampling limits generalizability.11 In any case, 
the rate of Pap test non-provision among physicians in the present survey was three times 
higher than the rate in the only comparison study10 identified, which was conducted 6 years 
earlier (28.4% vs 9%).
Implementation of the Patient Protection and Affordable Care Act18 is expected to remove 
financial barriers to preventive care services for millions of women.19,20 Primary care 
physicians will be ideally positioned to offer cervical cancer screening to women who have 
not had regular care. To maximize this opportunity, efforts to understand and address the 
barriers to cervical cancer screening in primary care settings may be needed.
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Table 1
Characteristics and screening beliefs by Pap test provision, U.S., DocStyles Survey, 2012 (N = 892)
n
Provision of Pap tests during a typical
month
Yes (%) No (%) p-value*
PHYSICIAN CHARACTERISTICS
Specialty
  Family practitioner 524 82.8 17.2 <0.001
  Internist 368 55.7 44.3
Gender
  Male 634 66.2 33.8 <0.001
  Female 258 84.9 15.1
Race
  White 649 72.0 28.0 0.649
  Asian 145 72.4 27.6
  Black 37 64.9 35.1
  Native American/Alaskan/Pacific Islander 6 83.3 16.7
  ≥2 races 30 80.0 20.0
  Other 35 62.9 37.1
Ethnicity
  Hispanic 43 74.4 25.6 0.678
  Non-Hispanic 849 71.5 28.5
Age (years)
  <40 221 71.9 28.1 0.675
  40–49 312 70.8 29.2
  50–59 267 73.8 26.2
  ≥60 92 67.4 32.6
Years in practice
  <10 217 72.4 27.6 0.699
  10–19 342 72.5 27.5
  20–29 260 71.5 28.5
  ≥30 73 65.8 34.2
PRACTICE CHARACTERISTICS
Number of physicians in practice
  Solo practitioner 135 74.8 25.2 0.293
  2–9 physicians 456 72.6 27.4
  10–19 physicians 122 64.8 35.2
  ≥20 physicians 179 71.5 28.5
Geographic region
  Northeast 246 57.7 42.3 <0.001
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n
Provision of Pap tests during a typical
month
Yes (%) No (%) p-value*
  South 197 72.1 27.9
  Midwest 209 81.8 18.2
  West 240 76.7 23.3
MSA with population >5 million
  Yes 250 56.8 43.2 <0.001
  No 642 77.4 22.6
MSA with population >3 million
  Yes 339 62.2 37.8 <0.001
  No 553 77.4 22.6
MSA with population >1 million
  Yes 476 65.1 34.9 <0.001
  No 416 79.1 20.9
Rural areaa
  Yes 81 85.2 14.8 0.005
  No 811 70.3 29.7
Primarily upper middle class-affluent patient population
  Yes 384 68.2 31.8 0.050
  No 508 74.2 25.8
Primarily very poor-lower middle class patient population
  Yes 157 76.4 23.6 0.142
  No 735 70.6 29.4
SCREENING BELIEFS
Patients are best served by having Pap tests performed by gynecologists
  Agree 174 29.9 70.1 <0.001
  Disagree 635 87.4 12.6
  Not sure 83 38.6 61.4
The reimbursement for Pap tests is typically too low to cover the costs associated with providing them
  Agree 208 69.2 30.8 <0.001
  Disagree 344 88.4 11.6
  Not sure 340 56.2 43.8
Women prefer to receive Pap tests from female providers
  Agree 562 75.1 24.9 <0.001
  Disagree 212 75.0 25.0
  Not sure 118 49.2 50.8
Note: Boldface indicates statistical significance, p < 0.05.
aAreas classified as outside of an MSA by the U.S. Office of Management and Budget
*
Pearson chi-square asymptotic two-sided tests
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MSA, Metropolitan Statistical Area
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Table 2
Significant predictors of Pap test non-provision, multivariate logistic regression,a U.S., DocStyles Survey, 
2012 (N = 892)
Predictive category AOR (95% CI) p-value* Reference category
PHYSICIAN CHARACTERISTICS
Specialty
  Internist 1.93 (1.31, 2.84) 0.001 Family practitioner
Gender
  Male 3.19 (1.97, 5.15) <0.001 Female
PRACTICE CHARACTERISTICS
Geographic region
  Northeast 2.19 (1.27, 3.77) 0.005 Midwest
  South 2.24 (1.25, 4.00) 0.007
  West 1.40 (0.79, 2.46) 0.248
MSA with population >5 million
  Yes 2.54 (1.68, 3.84) <0.001 No
SCREENING BELIEFS
Patients are best served by having Pap tests performed by gynecologists
  Agree 8.80 (5.58, 13.88) <0.001 Disagree
  Not sure 6.56 (3.76, 11.46) <0.001
The reimbursement for Pap tests is typically too low to cover the costs associated with providing them
  Agree 1.53 (0.89, 2.60) 0.121 Disagree
  Not sure 3.39 (2.10, 5.46) <0.001
Note: Table includes variables in the multivariate model with one or more significant categories. Boldface indicates statistical significance, p < 
0.05.
a
The model included the variables that were significantly associated with Pap test non-provision in unadjusted analyses: specialty, gender, 
geographic region, MSA with population >5 million, MSA with population >3 million, MSA with population >1 million, rural practice area, belief 
that patients are best served by having Pap test performed by gynecologists, belief that the reimbursement for Pap test is typically too low to cover 
the costs associated with providing them, and belief that women prefer to receive Pap tests from female providers.
*
Forward conditional logistic regression
MSA, Metropolitan Statistical Area
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